Importer of Controlled Substances Application: Clinical Supplies Management Holdings, Inc., 39127-39128 [2018-16939]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
appropriate Indian Tribes or Native
Hawaiian organizations, and has
determined that there is no cultural
affiliation between the human remains
and any present-day Indian Tribes or
Native Hawaiian organizations.
Representatives of any Indian Tribe or
Native Hawaiian organization not
identified in this notice that wish to
request transfer of control of these
human remains should submit a written
request to the NYU College of Dentistry.
If no additional requestors come
forward, transfer of control of the
human remains to the Indian Tribes or
Native Hawaiian organizations stated in
this notice may proceed.
DATES: Representatives of any Indian
Tribe or Native Hawaiian organization
not identified in this notice that wish to
request transfer of control of these
human remains should submit a written
request with information in support of
the request to the NYU College of
Dentistry at the address in this notice by
September 7, 2018.
ADDRESSES: Dr. Louis Terracio, NYU
College of Dentistry, 345 East 24th
Street, New York, NY 10010, telephone
(212) 998–9717, email louis.terracio@
nyu.edu.
SUPPLEMENTARY INFORMATION: Notice is
here given in accordance with the
Native American Graves Protection and
Repatriation Act (NAGPRA), 25 U.S.C.
3003, of the completion of an inventory
of human remains under the control of
the NYU College of Dentistry, New York
City, NY. The human remains were
removed from Shinnecock Hills, Suffolk
County, Long Island, NY.
This notice is published as part of the
National Park Service’s administrative
responsibilities under NAGPRA, 25
U.S.C. 3003(d)(3) and 43 CFR 10.11(d).
The determinations in this notice are
the sole responsibility of the museum,
institution, or Federal agency that has
control of the Native American human
remains. The National Park Service is
not responsible for the determinations
in this notice.
Suffolk County, NY. In 1926, the town
of Southampton donated the human
remains, which consist of the cranial
fragments of one adult, to the Museum
of the American Indian, Heye
Foundation. They were accessioned into
the collection of the Department of
Physical Anthropology of the Museum
of the American Indian, Heye
Foundation that same year. In 1956, the
human remains were transferred to Dr.
Theodore Kazamiroff, NYU College of
Dentistry. No known individuals were
identified. No associated funerary
objects are present. The age of the
human remains cannot be determined
from the available information. Forensic
examination revealed diagnostic
features of an individual with Native
American ancestry. Without any
information about the site or age of the
remains, no identifiable earlier group
can be determined.
Shinnecock Hills, which lies near the
northeastern end of Long Island, is not
included in any treaties, Acts of
Congress, or Executive Orders that
establish aboriginal land. The area is,
however, within territory that was long
recognized by the tribe, the town of
Southampton, and the state of New York
as Shinnecock land. In 1703, the
Shinnecock and town of Southampton
reached an agreement in which the
Shinnecock held a 1,000 year lease of
approximately 3,500 acres, including
Shinnecock Hills. The area was
subsequently referred to as the
Shinnecock Reservation in various state
and local documents. The Shinnecock
renegotiated their lease in 1859 and
relinquished the lands at Shinnecock
Hills in exchange for fee title to the land
at Shinnecock Neck. The current
Shinnecock Reservation, which no
longer includes Shinnecock Hills, was
placed into trust after the tribe was
federally recognized in 2010. The
Department of Interior proposed finding
on the Shinnecock petition for federal
recognition identifies Shinnecock Hills
as part of the pre-1859 Shinnecock
Reservation.
Consultation
A detailed assessment of the human
remains was made by the NYU College
of Dentistry professional staff in
consultation with representatives of the
Delaware Nation, Oklahoma; Delaware
Tribe of Indians; Shinnecock Indian
Nation; and Stockbridge Munsee
Community, Wisconsin.
Determinations Made by the NYU
College of Dentistry
Officials of the NYU College of
Dentistry have determined that:
• Pursuant to 25 U.S.C. 3001(9), the
human remains described in this notice
are Native American based on
diagnostic cranial features observed
during forensic examination.
• Pursuant to 25 U.S.C. 3001(9), the
human remains described in this notice
represent the physical remains of one
individual of Native American ancestry.
• Pursuant to 25 U.S.C. 3001(2), a
relationship of shared group identity
History and Description of the Remains
At an unknown date, human remains
representing, at minimum, one
individual were removed from an
unknown site in Shinnecock Hills,
VerDate Sep<11>2014
22:37 Aug 07, 2018
Jkt 244001
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
39127
cannot be reasonably traced between the
Native American human remains and
any present-day Indian Tribe.
• Authoritative governmental
documents, including the Shinnecock
Indian Nation’s federal recognition
decision, state agreements, and local
property records indicate that the land
from which the Native American human
remains were removed is the aboriginal
land of the Shinnecock Indian Nation.
• Pursuant to 43 CFR 10.11(c)(1), the
disposition of the human remains may
be to the Shinnecock Indian Nation.
Additional Requestors and Disposition
Representatives of any Indian Tribe or
Native Hawaiian organization not
identified in this notice that wish to
request transfer of control of these
human remains should submit a written
request with information in support of
the request to Dr. Louis Terracio, NYU
College of Dentistry, 345 East 24th
Street, New York, NY 10010, telephone
(212) 998–9717, email louis.terracio@
nyu.edu, by September 7, 2018. After
that date, if no additional requestors
have come forward, transfer of control
of the human remains to the Shinnecock
Indian Nation may proceed.
The NYU College of Dentistry is
responsible for notifying the Shinnecock
Indian Nation that this notice has been
published.
Dated: June 29, 2018.
Melanie O’Brien,
Manager, National NAGPRA Program.
[FR Doc. 2018–16920 Filed 8–7–18; 8:45 am]
BILLING CODE 4312–52–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Clinical Supplies
Management Holdings, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 7, 2018. Such
persons may also file a written request
for a hearing on the application on or
before September 7, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
DATES:
E:\FR\FM\08AUN1.SGM
08AUN1
39128
Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
29, 2018, Clinical Supplies Management
Holdings, Inc., 342 42nd Street South,
Fargo, North Dakota 58103–1132
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana .....................
Tetrahydrocannabinols
Drug
code
7360
7370
Schedule
I
I
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for use in clinical trials only.
Dated: July 31, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16939 Filed 8–7–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: AndersonBrecon Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 7, 2018. Such
persons may also file a written request
for a hearing on the application on or
before September 7, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
DATES:
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007)
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on May 2,
2018, AndersonBrecon Inc., 5775
Logistics Parkway, Rockford, Illinois
61109 applied to be registered as an
importer of the following basic class of
controlled substance:
Drug
code
Controlled substance
sradovich on DSK3GMQ082PROD with NOTICES
Tetrahydrocannabinols .........................................................................................................................................
The company plans to import the
listed controlled substances for clinical
trial only. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: July 31, 2018.
John J. Martin,
Assistant Administrator.
BILLING CODE 4410–09–P
22:37 Aug 07, 2018
Jkt 244001
Drug Enforcement Administration
[Docket No. DEA–392]
PO 00000
Notice of registration.
Frm 00088
Fmt 4703
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
Sfmt 4703
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Registration
VerDate Sep<11>2014
I
SUMMARY:
[FR Doc. 2018–16937 Filed 8–7–18; 8:45 am]
ACTION:
7370
Schedule
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 83, Number 153 (Wednesday, August 8, 2018)]
[Notices]
[Pages 39127-39128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16939]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Clinical Supplies
Management Holdings, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before September 7, 2018.
Such persons may also file a written request for a hearing on the
application on or before September 7, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be
[[Page 39128]]
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152. All request for hearing
should also be sent to: (1) Drug Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152;
and (2) Drug Enforcement Administration, Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on June
29, 2018, Clinical Supplies Management Holdings, Inc., 342 42nd Street
South, Fargo, North Dakota 58103-1132 applied to be registered as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for use in clinical trials only.
Dated: July 31, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-16939 Filed 8-7-18; 8:45 am]
BILLING CODE 4410-09-P
